Abstract:Myeloid cell leukemia-1 (Mcl-1) is a validated and attractive target for cancer therapy. Over-expression of Mcl-1 in many cancers allows cancer cells to evade apoptosis and contributes to their resistance to current chemotherapeutics. In this study, more than thirty coumarin derivatives with different substituents were designed and synthesized, and their Mcl-1 inhibitory activities evaluated using a fluorescence polarization-based binding assay. The results showed that the catechol group was a key constituent for Mcl-1 inhibitory activity of the coumarins, and methylation of the catechol group led to decreased inhibitory activity. The introduction of a hydrophobic electron-withdrawing group at the C-4 position of 6,7-dihydroxycoumarin, enhanced Mcl-1 inhibitory capacity, and a hydrophilic group in this position was unbeneficial to the inhibitory potency. In addition, the introduction of a nitrogen-containing group to the C-5 or C-8 position, which allowed an intramolecular hydrogen bond, was also unfavorable for Mcl-1 inhibition. Among all coumarins tested, 4-trifluoromethyl-6,7-dihydroxycoumarin (Cpd 4) displayed the most potent inhibitory activity towards Mcl-1 (Ki = 0.21 ± 0.02 μM, IC50 = 1.21 ± 0.56 μM, respectively), for which the beneficial effect on taxol resistance was also validated in A549 cells. A strong interaction between Cpd 4 and Mcl-1 in docking simulations further supported the observed potent Mcl-1 inhibition ability of Cpd 4. 3D-QSAR analysis of all tested coumarin derivatives further provides new insights into the relationships linking the inhibitory effects on Mcl-1 and the steric-electrostatic properties of coumarins. These findings could be of great value for medicinal chemists for the design and development of more potent Mcl-1 inhibitors for biomedical applications.

Synthesis of A Diverse Series of Phosphacoumarins with Biological Activity

Daphnetin, a Coumarin in Genus Stellera Chamaejasme Linn: Chemistry, Bioactivity and Therapeutic Potential

Synthesis and Biological Evaluation of Novel Phosphoramidate Derivatives of Coumarin As Chitin Synthase Inhibitors and Antifungal Agents

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Alkylation Reactions of Phosphachroman-2,4-diones and 4-Hydroxy Phosphacoumarins.

Synthesis of 4-Substituted Phosphacoumarins Via Cross-Coupling of 4-Tosylphosphacoumarins with Organozinc Reagents.

Synthesis and Structural Elucidation of P-stereogenic Coumarins

Synthesis of Some New 3-Cummamoyl Counarin Oximes and Related Cyclisation Products Derived from 3-Acetyl Coumarin

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Advances on Biological Activities of Coumarins

Coumarin hybrids: a sighting of their roles in drug targeting

Pharmacological And Nutritional Effects Of Natural Coumarins And Their Structure-Activity Relationships

[Research progress in biosynthesis-related enzymes of coumarin compounds and their bioactivities]

Synthesis and biological evaluation of novel 3-substituted amino-4-hydroxylcoumarin derivatives as chitin synthase inhibitors and antifungal agents

Synthesis, Bioactivity, Pharmacokinetic and Biomimetic Properties of Multi-Substituted Coumarin Derivatives

Pharmacological and Nutritional Effects of Natural Coumarins and Their Structure–Activity Relationships

Advances in Pharmacology and Toxicology of Coumarins

Synthesis and Anti-Angiogenesis Activity of Coumarin Derivatives.

Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment

Diastereoselective Synthesis of Novel Spiro-Phosphacoumarins and Evaluation of Their Anti-Cancer Activity

Syntheses, reactivity, and biological applications of coumarins